Markers of bone turnover are associated with growth and development in young subjects with sickle cell anemia

Pediatric Blood and Cancer

Volumn 50, Issue 3, 2008, Pages 620-623

  Fung, Ellen B ^a   Kawchak, Deborah A ^b   Zemel, Babette S ^b   Rovner, Alisha J ^b   Ohene Frempong, Kwaku ^b   Stallings, Virginia A ^b  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bone markers; Bone mineral content; Bone mineral density; Growth; Sickle cell anemia

Indexed keywords

ALKALINE PHOSPHATASE; DEOXYPYRIDINOLINE;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; CHILD; CHILD DEVELOPMENT; CHILD GROWTH; FEMALE; GROWTH RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; PUBERTY; SICKLE CELL ANEMIA;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ALKALINE PHOSPHATASE; AMINO ACIDS; ANEMIA, SICKLE CELL; BIOLOGICAL MARKERS; BODY WEIGHT; BONE DENSITY; BONE RESORPTION; CHILD; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; MALE; OSTEOCALCIN; OSTEOPOROSIS; PARATHYROID HORMONE; PUBERTY, DELAYED;

EID: 38549166241     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21147     Document Type: Article

References (20)

1. Lal A, Fung EB, Pakbaz Z, et al. Bone mineral density in children with sickle cell disease. Pediatr Blood Cancer 2006;47:901-906.
2. Brinker MR, Thomas KA, Meyers SJ. Bone mineral density of lumbar spine and proximal femur in children with sickle cell disease. Am J Orthopedics 1998;27:43-49.
3. Buison AM, Kawchak DA, Schall J, et al. Bone area and bone mineral content deficits in children with sickle cell disease. Pediatrics 2005;116:943-949.
4. Serjeant G, Serjeant B. Bone and joint lesions. In: Sickle Cell Disease. New York, NY: Oxford: Oxford University Press; 2001. pp 240-280.
5. Onuba O. Bone disorders in sickle cell disease. Int Orthop 1993;17:397-399.
6. Barden EM, Zemel BS, Kawchak DA, et al. Total and resting energy expenditure in children with sickle cell disease. J Pediatr 2000;136:73-79.
7. Soliman AT, Bererhi H, Sarwish A, et al. Decreased bone mineral density in pubertal children with SCD: Correlation with growth parameters, degree of siderosis and secretion of growth factors. J Trop Pediatr 1998;44:194-198.
8. Buison AM, Kawchak DA, Schall J, et al. Low vitamin D status in children with sickle cell disease. J Pediatr 2004;145:622-627.
9. Williams R, George EO, Wang W. Nutrition assessment in children with sickle cell disease. J Assoc Acad Minority Physicians 1997;8:44-48.
10. Heaney RP, Abrams S, Dawson-Hughes B, et al. Peak bone mass. Osteoporosis Int 2000;11:985-1009.
11. Morris NM, Udry JR. Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc 1980;9:271-280.
12. Mora S, Pitukcheewanont P, Kaufman FR, et al. Biochemical markers of bone turnover and the volume and density of bone in children at different stages of sexual development. J Bone Min Res 1999;14:1664-1671.
13. Rauch F, Georg M, Stabrey A, et al. Collagen markers deoxypyridinoline and hydroxylysine glycosides: Pediatric reference data and use for growth prediction in growth hormone deficient children. Clin Chem 2002;48:315-322.
14. Chailurkit L, Suthutvoravut U, Mahachoklertwattana P, et al. Biochemical markers of bone formation in Thai children and adolescents. Endocr Res 2005;31:159-169.
15. Crofton PM, Kelnar CJH. Bone and collagen markers in pediatric practice. Int J Clin Pract 1998;52:557-565.
16. VanderJagt DJ, Bonnett C, Okolo SN, et al. Assessment of bone status of Nigerian children and adolescents with sickle cell disease using calcaneal ultrasound and serum markers of bone turnover. Calcif Tissue Int 2002;71:133-140.
17. Buchowski MS, De La Fuente FA, Flakoll PJ, et al. Increased bone turnover is associated with protein and energy metabolism in adolescents with sickle cell anemia. Am J Physiol Endocrinol Metab 2001;280:E518-E527.
18. Bolarin DM. Bone specific alkaline phosphatase protein, total alkaline phosphatase activity and lactate dehydrogenase in sera of patients with sickle cell disease. Haematologica 2001;31:51-56.
19. Bringhurst FR, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism. In: Larsen PR, Kronenberg HM, Melmed S, et al., editors. Williams Textbook of Endocrinology. Philadelphia: WB Saunders; 2003. pp 1318-1320.
20. Zemel BS, Kawchak DA, Fung EB, et al. Effect of zinc supplementation on growth and body composition in children with sickle cell disease. Am J Clin Nutr 2002;75:300-307.